LEFFORD M, Logie P
Infect Immun. 1981; 31(3):1023-33.
PMID: 6785237
PMC: 351421.
DOI: 10.1128/iai.31.3.1023-1033.1981.
Nepom G, Hellstrom I, Hellstrom K
Experientia. 1983; 39(3):235-42.
PMID: 6186519
DOI: 10.1007/BF01955286.
Embleton M
Br J Cancer Suppl. 1973; 1:142-52.
PMID: 4804277
PMC: 2149074.
Cooper A, CODINGTON J, Brown M
Proc Natl Acad Sci U S A. 1974; 71(4):1224-8.
PMID: 4524634
PMC: 388197.
DOI: 10.1073/pnas.71.4.1224.
Forni G, Comoglio P
Br J Cancer. 1974; 30(4):365-9.
PMID: 4447779
PMC: 2009285.
DOI: 10.1038/bjc.1974.206.
Effect of splenectomy on the growth of adenovirus 12 tumors in hamsters.
Erb P, Baselgia L, Gasser M, Honegger A, Loeffler H
Experientia. 1974; 30(8):943-4.
PMID: 4413092
DOI: 10.1007/BF01938376.
Immunogenicity of rat hepatoma membrane fractions.
Baldwin R, Embleton M, Moore M
Br J Cancer. 1973; 28(5):389-99.
PMID: 4357132
PMC: 2008927.
DOI: 10.1038/bjc.1973.164.
Prognostic role of antibody reactivity to melanoma.
Vlock D, DerSimonian R, Kirkwood J
J Clin Invest. 1986; 77(4):1116-21.
PMID: 3958183
PMC: 424445.
DOI: 10.1172/JCI112410.
Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.
Vlock D, Kirkwood J
J Clin Invest. 1985; 76(2):849-54.
PMID: 3875634
PMC: 423916.
DOI: 10.1172/JCI112042.
Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.
Bhatti R, Shaw M, Ray P
Experientia. 1987; 43(8):916-7.
PMID: 3622734
DOI: 10.1007/BF01951666.
Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.
Yang T, Palker T, Harding M
Cancer Immunol Immunother. 1991; 33(4):255-62.
PMID: 2059969
PMC: 11038260.
DOI: 10.1007/BF01744945.
Leukemia in AKR mice. I. Effects of leukemic cells on antibody-forming potential of syngeneic and allogeneic normal cells.
Roman J, Golub E
J Exp Med. 1976; 143(3):482-96.
PMID: 942993
PMC: 2190145.
DOI: 10.1084/jem.143.3.482.
Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
Mitchell M, Mokyr M, Davis J
J Clin Invest. 1977; 59(6):1017-26.
PMID: 863999
PMC: 372313.
DOI: 10.1172/JCI108724.
Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.
Lee W, REED W, Osman C, VAHRMAN J, Zuckerman A, Eddleston A
Gut. 1977; 18(3):250-7.
PMID: 856683
PMC: 1411397.
DOI: 10.1136/gut.18.3.250.
Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.
Matthews N, Chalmers P, Flannery G, Nairn R
Br J Cancer. 1976; 33(3):279-89.
PMID: 773397
PMC: 2024971.
DOI: 10.1038/bjc.1976.41.
Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.
Brandeis W, Helson L, Wang Y, GOOD R, Day N
J Clin Invest. 1978; 62(6):1201-9.
PMID: 748375
PMC: 371885.
DOI: 10.1172/JCI109240.
Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.
LEFFORD M, Patel P, Poulter L, Mackaness G
Infect Immun. 1977; 18(3):654-9.
PMID: 338487
PMC: 421285.
DOI: 10.1128/iai.18.3.654-659.1977.
Suppression of immunity to Mycobacterium lepraemurium infection.
LEFFORD M, Mackaness G
Infect Immun. 1977; 18(2):363-9.
PMID: 336544
PMC: 421241.
DOI: 10.1128/iai.18.2.363-369.1977.
Recovery of immune competence after tumour resection in mice: correlation with loss of suppressor elements.
Gasocyne R, Whitney R, LEVY J
Br J Cancer. 1978; 37(2):190-8.
PMID: 305254
PMC: 2009602.
DOI: 10.1038/bjc.1978.27.
Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.
Embleton M
Br J Cancer. 1976; 33(6):584-92.
PMID: 181041
PMC: 2025102.
DOI: 10.1038/bjc.1976.95.
